Back to search

Article

A tumor metabolism-angiogenesis-immune axis governs immunotherapy responses

2026-02-24

Abstract excerpt

Despite the clinical success of immunotherapy, long-lasting benefit remains restricted to a subset of patients. Tumor metabolic adaptation is emerging as a key factor limiting immunotherapy efficacy. We previously found that glycolysis-low tumor variants, compared to the parental glycolytic tumors, better respond to neoadjuvant CTLA-4 immune checkpoint blockade (ICB) therapy. Here, we investigated new rational mod...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9dea7c5e-e0a3-5c45-8bf5-deb09abcc3fd
DOI
10.64898/2026.02.23.707524
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesDOI 10.64898/2026.02.23.707524
Select a neighboring publication to make it the new centre.